BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294 | -20.3% | 41,497 | -20.8% | 0.02% | -24.1% |
Q2 2023 | $369 | -5.1% | 52,423 | +12.5% | 0.03% | +3.6% |
Q1 2023 | $389 | -15.8% | 46,585 | +15.7% | 0.03% | -26.3% |
Q4 2022 | $462 | -99.9% | 40,255 | +13.7% | 0.04% | -9.5% |
Q3 2022 | $446,000 | -5.1% | 35,417 | -20.2% | 0.04% | -2.3% |
Q2 2022 | $470,000 | +73.4% | 44,408 | +166.9% | 0.04% | +377.8% |
Q1 2022 | $271,000 | +31.6% | 16,641 | +11.8% | 0.01% | +28.6% |
Q4 2021 | $206,000 | +26.4% | 14,885 | +31.2% | 0.01% | 0.0% |
Q3 2021 | $163,000 | +45.5% | 11,349 | +3.5% | 0.01% | -22.2% |
Q1 2021 | $112,000 | – | 10,970 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |